Pharmacies GOFFIN: what changed
What changed
Pharmacies GOFFIN
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Net result for the year
€20,871
2024 · €46,251-€25,380
Equity
€235,148
2024 · €219,277+€15,871
Cash
€13,730
2024 · €81,866-€68,136
Balance sheet total
€771,286
2024 · €710,768+€60,518
Largest movements
Assets
- Receivables within one year +€118,634
up €118,634 (+97.3%), from €121,875 to €240,509
of which Trade receivables: +€116,883
- Cash -€68,136
down €68,136 (-83.2%), from €81,866 to €13,730
mainly Receivables within one year (-€118,634) and Other debts (-€35,000)
- Stocks and contracts +€15,849
up €15,849 (+7.1%), from €224,771 to €240,619
- Financial fixed assets -€12,166
down €12,166 (-5.9%), from €205,441 to €193,274
- Tangible fixed assets +€12,025
up €12,025 (+19.2%), from €62,728 to €74,753
of which Furniture and vehicles: +€33,972
Equity and liabilities
- Trade debts +€80,920
up €80,920 (+46.0%), from €176,029 to €256,949
- Other debts -€35,000
down €35,000 (-43.8%), from €80,000 to €45,000
- Reserves +€15,000
up €15,000 (+9.6%), from €156,250 to €171,250
of which Distributable reserves: +€15,000
- Current portion of long-term debt +€11,401
up €11,401 (+31.7%), from €35,933 to €47,334
- Debts after one year -€10,713
down €10,713 (-8.5%), from €126,229 to €115,516
of which Trade debts: -€76,500
Income statement
- Staff costs +€17,982
up €17,982 (+5.0%), from €356,406 to €374,389
- Depreciation +€6,343
up €6,343 (+28.0%), from €22,639 to €28,982
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€46,251
Gross operating margin
+€2,568
Staff costs
-€17,982
Depreciation
-€6,343
Other operating charges
+€942
Other operating items
+€138
Financial income
-€2,229
Financial charges
-€4,352
Taxes
+€1,878
Result 2025
€20,871
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
-€34,984
Investment
-€28,841
Financing
-€4,311
Cash 2024
€81,866
From operations (derived)
-€34,984
Net result for the year
+€20,871
Depreciation
+€28,982
Stocks and contracts
-€15,849
Receivables within one year
-€118,634
Deferred charges and accrued income
+€5,687
Trade debts
+€80,920
Tax, wage and social debts
-€1,373
Other debts
-€35,000
Accrued charges and deferred income
-€589
Investment (derived)
-€28,841
Investment in fixed assets (net)
-€28,841
Financing
-€4,311
Debts after one year
-€10,713
Current portion of long-term debt
+€11,401
Contributions, distributions and other
-€5,000
Cash 2025
€13,730
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €710,768 | €771,286 | +€60,518 | +8.5% |
| Fixed assets | 21/28 | €268,168 | €268,027 | -€141 | -0.1% |
| Tangible fixed assets | 22/27 | €62,728 | €74,753 | +€12,025 | +19.2% |
| Plant, machinery and equipment | 23 | €55,376 | €34,430 | -€20,947 | -37.8% |
| Furniture and vehicles | 24 | €6,351 | €40,323 | +€33,972 | +535% |
| Assets under construction and advance payments | 27 | €1,000 | - | -€1,000 | |
| Financial fixed assets | 28 | €205,441 | €193,274 | -€12,166 | -5.9% |
| Current assets | 29/58 | €442,600 | €503,259 | +€60,659 | +13.7% |
| Stocks and contracts in progress | 3 | €224,771 | €240,619 | +€15,849 | +7.1% |
| Stocks | 30/36 | €224,771 | €240,619 | +€15,849 | +7.1% |
| Amounts receivable within one year | 40/41 | €121,875 | €240,509 | +€118,634 | +97.3% |
| Trade receivables | 40 | €121,059 | €237,942 | +€116,883 | +96.6% |
| Other amounts receivable | 41 | €817 | €2,567 | +€1,751 | +214% |
| Cash at bank and in hand | 54/58 | €81,866 | €13,730 | -€68,136 | -83.2% |
| Deferred charges and accrued income | 490/1 | €14,088 | €8,401 | -€5,687 | -40.4% |
| Total equity and liabilities | 10/49 | €710,768 | €771,286 | +€60,518 | +8.5% |
| Equity | 10/15 | €219,277 | €235,148 | +€15,871 | +7.2% |
| Contributions | 10/11 | €62,500 | €62,500 | = | 0.0% |
| Capital | 10 | €62,500 | €62,500 | = | 0.0% |
| Issued capital | 100 | €62,500 | €62,500 | = | 0.0% |
| Reserves | 13 | €156,250 | €171,250 | +€15,000 | +9.6% |
| Non-distributable reserves | 130/1 | €6,250 | €6,250 | = | 0.0% |
| Legal reserve | 130 | €6,250 | €6,250 | = | 0.0% |
| Distributable reserves | 133 | €150,000 | €165,000 | +€15,000 | +10.0% |
| Profit (loss) carried forward | 14 | €527 | €1,398 | +€871 | +165% |
| Amounts payable | 17/49 | €491,491 | €536,138 | +€44,647 | +9.1% |
| Amounts payable after more than one year | 17 | €126,229 | €115,516 | -€10,713 | -8.5% |
| Financial debts | 170/4 | €49,729 | €115,516 | +€65,787 | +132% |
| Trade debts | 175 | €76,500 | - | -€76,500 | |
| Amounts payable within one year | 42/48 | €362,784 | €418,733 | +€55,948 | +15.4% |
| Current portion of amounts payable after more than one year | 42 | €35,933 | €47,334 | +€11,401 | +31.7% |
| Trade debts | 44 | €176,029 | €256,949 | +€80,920 | +46.0% |
| Suppliers | 440/4 | €176,029 | €256,949 | +€80,920 | +46.0% |
| Taxes, remuneration and social security | 45 | €70,823 | €69,450 | -€1,373 | -1.9% |
| Taxes | 450/3 | €17,292 | €14,264 | -€3,029 | -17.5% |
| Remuneration and social security | 454/9 | €53,530 | €55,186 | +€1,656 | +3.1% |
| Other amounts payable | 47/48 | €80,000 | €45,000 | -€35,000 | -43.8% |
| Accrued charges and deferred income | 492/3 | €2,478 | €1,889 | -€589 | -23.8% |
| Non-recurring operating income | 76A | - | €4,500 | +€4,500 | |
| Remuneration, social security and pensions | 62 | €356,406 | €374,389 | +€17,982 | +5.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €22,639 | €28,982 | +€6,343 | +28.0% |
| Other operating charges | 640/8 | €1,843 | €902 | -€942 | -51.1% |
| Non-recurring operating charges | 66A | €138 | - | -€138 | |
| Gross operating margin | 9900 | €436,261 | €438,828 | +€2,568 | +0.6% |
| Operating profit (loss) | 9901 | €55,234 | €34,556 | -€20,678 | -37.4% |
| Financial income | 75/76B | €5,318 | €3,089 | -€2,229 | -41.9% |
| Recurring financial income | 75 | €5,318 | €3,089 | -€2,229 | -41.9% |
| Financial charges | 65/66B | €4,645 | €8,997 | +€4,352 | +93.7% |
| Recurring financial charges | 65 | €4,645 | €8,997 | +€4,352 | +93.7% |
| Profit (loss) for the period before taxes | 9903 | €55,907 | €28,648 | -€27,259 | -48.8% |
| Income taxes | 67/77 | €9,656 | €7,777 | -€1,878 | -19.5% |
| Profit (loss) for the period | 9904 | €46,251 | €20,871 | -€25,380 | -54.9% |
| Profit (loss) for the period to be appropriated | 9905 | €46,251 | €20,871 | -€25,380 | -54.9% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.